Aflibercept Dose in Polypoidal Choroidal Vasculopathy

JAMA Ophthalmology Author Interviews: Covering research, science, & clinical practice in ophthalmology and vision science by American Medical Association

Interview with Tien Y. Wong, MD, PhD, author of Aflibercept 8 mg in Polypoidal Choroidal Vasculopathy: Post Hoc Analysis of the PULSAR Randomized Clinical Trial. Hosted by Neil Bressler, MD. Related Content: Aflibercept...View more